Literature DB >> 3297033

Glycophorin A interferes in the agglutination of human erythrocytes by concanavalin A. Explanation of the requirement for enzymic predigestion.

S M Gokhale, N G Mehta.   

Abstract

Human erythrocytes become agglutinable with concanavalin A (Con A) after treatment with various proteinases or neuraminidase. The extent of agglutinability achieved with different enzymes is, however, different: Pronase, papain, trypsin, neuraminidase and chymotrypsin enhance the agglutinability in decreasing order, the last being barely effective. The actions of the enzymes on band 3, the Con A receptor, do not correlate with their abilities to increase the agglutinability: Pronase, papain and chymotrypsin cleave the protein, but not trypsin or neuraminidase. No significant differences are found in the number of Con A-binding sites or the affinities for the lectin between the normal and trypsin- or Pronase-treated cells. Thus the receptor does not seem to play a role in determining the Con A-agglutinability of erythrocytes. On the other hand, the cleavage of glycophorins, especially glycophorin A, and the release of sialic acid (in the peptide-bound form) are well-correlated with the enhancement in agglutination after the action of proteinases. The release of sialic acid by graded neuraminidase digestion and the increase in Con A-agglutinability show a correlation coefficient of 0.88. The major inhibitory role of glycophorin A in the process is indicated by the agglutination of En(a) heterozygous erythrocytes; the cells, known to bear about 50% glycophorin A molecules in their membrane, are agglutinated approximately half as well without proteolysis as are the trypsin-treated cells. Possible mechanisms by which glycophorin A could affect Con A-mediated agglutination are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297033      PMCID: PMC1147589          DOI: 10.1042/bj2410505

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Reaction of lectins with human erythrocytes. I. Factors governing the agglutination reaction.

Authors:  H P Schnebli; T Bächi
Journal:  Exp Cell Res       Date:  1975-03-01       Impact factor: 3.905

2.  Reaction of lectins with human erythrocytes. III. Surface charge density and agglutination.

Authors:  H P Schnebli; C Roeder; L Tarcsay
Journal:  Exp Cell Res       Date:  1976-03-15       Impact factor: 3.905

3.  Absence of the major sialoglycoprotein in the membrane of human En(a--) erythrocytes and increased glycosylation of band 3.

Authors:  C G Gahmberg; G Myllyla; J Leikola; A Pirkola; S Nordling
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

4.  Abnormal carbohydrate composition of the major penetrating membrane protein of En(a-) human erythrocytes.

Authors:  M J Tanner; R E Jenkins; D J Anstee; J R Clamp
Journal:  Biochem J       Date:  1976-06-01       Impact factor: 3.857

5.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

6.  Further observations on substrate-derived chloromethyl ketones that inactivate trypsin.

Authors:  E Shaw; G Glover
Journal:  Arch Biochem Biophys       Date:  1970-08       Impact factor: 4.013

7.  Arrangement of human erythrocyte membrane proteins.

Authors:  E Reichstein; R Blostein
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

8.  Platelet glycocalicin. II. Purification and characterization.

Authors:  I Okumura; C Lombart; G A Jamieson
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

9.  The membrane change in En(a-) human erythrocytes. Absence of the major erythrocyte sialoglycoprotein.

Authors:  M J Tanner; D J Anstee
Journal:  Biochem J       Date:  1976-02-01       Impact factor: 3.857

Review 10.  Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1976-04-30
View more
  8 in total

1.  Contact patterns in concanavalin A agglutinated erythrocytes.

Authors:  H Darmani; W T Coakley
Journal:  Cell Biophys       Date:  1991-02

2.  Modification of the erythrocyte surface in rats bearing Yoshida ascites sarcoma is brought about by a tumour variant of alpha2-macroglobulin.

Authors:  A Sanjay; R D Kalraiya; N G Mehta
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Immunomodulatory and hemagglutinating activities of acidic polysaccharides isolated from Combretum racemosum.

Authors:  Igor A Schepetkin; Koffi Kouakou; Ahoua Yapi; Liliya N Kirpotina; Mark A Jutila; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2013-02-01       Impact factor: 4.932

4.  Influence of polymer concentration and molecular weight and of enzymic glycocalyx modification on erythrocyte interaction in dextran solutions.

Authors:  A J Baker; W T Coakley; D Gallez
Journal:  Eur Biophys J       Date:  1993       Impact factor: 1.733

5.  Concanavalin A-agglutinability of membrane-skeleton-free vesicles and aged cellular remnants derived from human erythrocytes. Is the membrane skeleton required for agglutination?

Authors:  S M Gokhale; N G Mehta
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Effect of erythropoietin on the interaction of concanavalin A with rat erythrocytes.

Authors:  T Biswas; M Chakraborty; C K Ganguly; J Ghosal
Journal:  Mol Cell Biochem       Date:  1991-08-14       Impact factor: 3.396

7.  Isolation of a glycoprotein responsible for the enhanced concanavalin A agglutinability of erythrocytes in Yoshida-ascites-sarcoma-bearing rats: the mechanism of paraneoplastic syndromes.

Authors:  R D Kalraiya; A Sanjay; N G Mehta
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

8.  Membrane perturbations induced by the interactions of zinc ions with band 3 in human erythrocytes.

Authors:  Kento Kiyoatake; Shigemi Nagadome; Takeo Yamaguchi
Journal:  Biochem Biophys Rep       Date:  2015-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.